[New insight into the treatment of aortic stenosis]

Philippe Pibarot1, Jean G Dumesnil, Patrick Mathieu

  • 1Centre de recherche de l'Hôpital Laval, Institut de cardiologie de Québec, Université Laval, 2725, chemin Sainte-Foy, Sainte-Foy, Québec, G1V 4G5 Canada. philippe.pibarot@med.ulaval.ca

Medecine Sciences : M/S
|January 11, 2007
PubMed

Insights

Aortic valve stenosis (AS) is a common heart disease. New research shows AS involves the whole arterial system, not just the valve, suggesting new treatment approaches.

Area of Science:

  • Cardiovascular Medicine
  • Pathophysiology
  • Biomedical Research

Context:

  • Aortic valve stenosis (AS) is a prevalent cardiovascular condition, second only to coronary artery disease and hypertension.
  • Historically viewed as a degenerative process due to aging, recent evidence suggests AS shares similarities with atherosclerosis.
  • Growing understanding indicates AS is interconnected with systemic arterial abnormalities, particularly reduced arterial compliance.

Purpose:

  • To re-evaluate the understanding of aortic valve stenosis (AS) beyond a localized valvular disease.
  • To highlight the pathophysiological links between AS, systemic arterial health, and left ventricular function.
  • To advocate for a comprehensive evaluation approach in managing AS.

Summary:

  • Calcific aortic valve stenosis (AS) exhibits histological similarities to atherosclerosis, implying potential for therapeutic modification.
  • AS is frequently associated with systemic arterial disease, notably reduced arterial compliance, impacting disease outcomes.
  • A holistic assessment of the aortic valve, systemic arteries, and left ventricle is crucial for effective AS management.

Impact:

  • Shifts the paradigm of AS from a degenerative valve condition to a systemic disease process.
  • Opens avenues for lifestyle and pharmacological interventions targeting AS.
  • Emphasizes the need for integrated diagnostic and therapeutic strategies in cardiovascular care.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...